Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8591 |
High Similarity |
NPD1653 |
Approved |
0.8489 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8417 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8252 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8252 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8212 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8141 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8116 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8089 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8077 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8061 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7962 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7881 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7862 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7829 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7806 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7793 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7792 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7785 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7725 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7711 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7698 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7679 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7636 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7633 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7593 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7582 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7566 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7545 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7467 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7467 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7456 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7453 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7386 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD919 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7193 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7179 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7132 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7125 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7115 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7102 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7091 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7076 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7071 |
Intermediate Similarity |
NPD228 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7059 |
Intermediate Similarity |
NPD943 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7228 |
Approved |
0.703 |
Intermediate Similarity |
NPD37 |
Approved |
0.7021 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7014 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4966 |
Approved |
0.6993 |
Remote Similarity |
NPD6671 |
Approved |
0.6981 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6971 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6959 |
Remote Similarity |
NPD9717 |
Approved |
0.6957 |
Remote Similarity |
NPD968 |
Approved |
0.6948 |
Remote Similarity |
NPD1240 |
Approved |
0.6943 |
Remote Similarity |
NPD2796 |
Approved |
0.6933 |
Remote Similarity |
NPD3266 |
Approved |
0.6933 |
Remote Similarity |
NPD3267 |
Approved |
0.6928 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6918 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD5677 |
Discontinued |
0.6879 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6875 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD1607 |
Approved |
0.6848 |
Remote Similarity |
NPD3226 |
Approved |
0.6846 |
Remote Similarity |
NPD1608 |
Approved |
0.6842 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6839 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6838 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6835 |
Remote Similarity |
NPD6099 |
Approved |
0.6835 |
Remote Similarity |
NPD6100 |
Approved |
0.6821 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD411 |
Approved |
0.6813 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD1243 |
Approved |
0.681 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.681 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD4675 |
Approved |
0.6807 |
Remote Similarity |
NPD4678 |
Approved |
0.6803 |
Remote Similarity |
NPD9268 |
Approved |
0.6792 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6786 |
Remote Similarity |
NPD1358 |
Approved |
0.6772 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6766 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD5089 |
Approved |
0.6766 |
Remote Similarity |
NPD5090 |
Approved |
0.6765 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6763 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6757 |
Remote Similarity |
NPD1778 |
Approved |
0.6757 |
Remote Similarity |
NPD4626 |
Approved |
0.6748 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6748 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6746 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6736 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6732 |
Remote Similarity |
NPD9494 |
Approved |
0.673 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6728 |
Remote Similarity |
NPD2354 |
Approved |
0.6727 |
Remote Similarity |
NPD920 |
Approved |
0.6724 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6711 |
Remote Similarity |
NPD987 |
Approved |
0.671 |
Remote Similarity |
NPD1048 |
Approved |
0.671 |
Remote Similarity |
NPD3764 |
Approved |
0.6708 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6708 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD3536 |
Discontinued |
0.6707 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.669 |
Remote Similarity |
NPD3022 |
Approved |
0.669 |
Remote Similarity |
NPD3021 |
Approved |
0.6688 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD3687 |
Approved |
0.6687 |
Remote Similarity |
NPD3686 |
Approved |
0.6687 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6686 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6686 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6667
|
Remote Similarity |
NPD5049 |
Phase 3 |